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Abstract
Background: The availability of well-annotated prostate tissue samples through biobanks is key for research.
Whereas fresh-frozen tissue is well suited for a broad spectrum of molecular analyses, its storage and handling is
complex and cost-intensive. Formalin-fixed paraffin-embedded specimens (FFPE) are easy to handle and economic
to store, but their applicability for molecular methods is restricted. The recently introduced Hepes-glutamic acid-
buffer mediated Organic solvent Protection Effect (HOPE) is a promising alternative, which might have the
potential to unite the benefits of FFPE and fresh-frozen specimen. Aim of the study was to compare HOPE-fixed,
FFPE and fresh-frozen bio-specimens for their accessibility for diagnostic and research purposes.
Methods: 10 prostate cancer samples were each preserved with HOPE, formalin, and liquid nitrogen and studied
with in-situ and molecular methods. Samples were H&E stained, and assessed by immunohistochemistry (i.e. PSA,
GOLPH2, p63) and FISH (i.e. ERG rearrangement). We assessed DNA integrity by PCR, using control genes ranging
from 100 to 600 bp amplicon size. RNA integrity was assessed through qRT-PCR on three housekeeping genes
(TBP, GAPDH, b-actin). Protein expression was analysed by performing western blot analysis using GOLPH2 and PSA
antibodies.
Results: Of the HOPE samples, morphologic quality of H&E sections, immunohistochemical staining, and the FISH
assay was at least equal to FFPE tissue, and significantly better than the fresh-frozen specimens. DNA, RNA, and
protein analysis of HOPE samples provided similar results as compared to fresh-frozen specimens. As expected,
FFPE-samples were inferior for most of the molecular analyses.
Conclusions: This is the first study, comparatively assessing the suitability of these fixation methods for diagnostic
and research utilization. Overall, HOPE-fixed bio-specimens combine the benefits of FFPE- and fresh-frozen samples.
Results of this study have the potential to expand on contemporary prostate tissue biobanking approaches and
can serve as a model for other organs and tumors.
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Background
The importance of prostate tissue bio-repositories is
increasing as they are forming an invaluable resource of
samples for profound translational research [1-4]. Long
term and, preferably, native preservation is an essential
requirement of stored samples. Due to the nature of
prostate carcinomas which commonly develops multiple
and independent tumor foci, they are difficult to identify
macroscopically. For research purposes, it is recom-
mended to fresh-freeze each second prostate slice in
order to capture the tumour with all foci [2,5-7]. Thus,
comprehensive prostate cancer biobanking requires sig-
nificant amounts of resources, and large patient counts
would eventually exhaust the bio-repository in a short
period of time. In conflict with the recommendation of
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d e m a n dt h ee m b e d d i n go ft h ec o m p l e t ep r o s t a t ef o r
routine diagnosis, almost exclusively conducted via for-
malin-fixation and subsequent paraffin-embedding
(FFPE). This leads to a restriction in the amount of
available quality tissue for research.
Whilst the limitedly available fresh-frozen tissue is
most applicable to a broad spectrum of molecular ana-
lyses, its storage and handling is complex and cost-
intensive. On the other hand, the abundantly available
FFPE specimens are easy to handle and economic to
store, but their applicability for modern analysis meth-
ods is restricted [7-12]. The recently introduced, forma-
lin-free Hepes-glutamic acid buffer mediated Organic
solvent Protection Effect (HOPE) fixation method is a
promising alternative, which might have the potential to
unite the benefits of FFPE and fresh-frozen specimen.
By this means, the HOPE fixed specimen may have the
potential to overcome the problems being faced by both
the research and diagnostics. HOPE-fixed specimens
have been used for several studies and their viability has
been assessed on different human tissues using several
molecular methods [13-24]. However, no studies have
been reported so far, parallely assessing the advantages
and disadvantages of FFPE, fresh-frozen and HOPE-
fixed prostate specimens. Thus, the aim of our study
was to comprehensively compare fresh-frozen samples,
HOPE-fixed samples, and FFPE samples for their appli-
cation to common morphologic and molecular methods
(i.e. H&E staining, immuhistochemistry, DNA and RNA
extraction, PCR, qRT-PCR, western blotting and fluores-
cence in-situ hybridization). Results of this study could
have the potential to expand on contemporary prostate
tissue biobanking approaches.
Methods
Material
All experiments were performed on a radical prostatect-
omy cohort of 10 patients diagnosed and treated at the
University Hospital of Tubingen, Germany. For each
patient, we identified normal prostatic tissue and pros-
tate cancer tissue from the 10 corresponding prostatect-
omy samples.
Benign and cancerous prostatic tissues were separated
into three portions of equal size. Subsequently, the three
portions were fixed using the conventional FFPE protocol,
the recently introduced HOPE-fixation, and cryo-conser-
vation method. HOPE-fixation was been performed as
described earlier [18]. For detailed protocols, refer to sup-
plementary information (see Additional file 1).
H&E staining and immunohistochemistry
For H&E staining and immunohistochemistry, 2.5 μm
sections of all fixed samples were mounted on
superfrost slides. For immunohistochemistry pre-treat-
ment, the FFPE and HOPE sections were deparaffinised,
using EZ Preparation Buffer, pH 7.0, followed by stabili-
zation reaction with TRIS Buffer, pH = 7.6-7.8 (Ventana
Medical Systems, Tucson, AZ, USA). Immunohisto-
chemistry was conducted with the Ventana Benchmark
automated staining system (Ventana Medical Systems,
Tucson, AZ, USA) using Ventana reagents. For immu-
nohistochemical staining, the following clones and pri-
mary antibodies were used: prostate-specific antigen
(PSA) antibody (clone 35H9, Novocastra, Newcastle,
UK, dilution 1:50), GOLPH2 antibody (clone 5B10;
Abnova, Heidelberg, Germany, dilution 1:1000), p63
antibody (clone 4A4; DAKO, Haverlee, Belgium, dilution
1:100). No epitope retrieval has been performed for the
HOPE and fresh-frozen sections. Multiple board-certi-
fied pathologists did the evaluation of the slides inde-
pendently. Criteria for a sufficient staining were
antibody binding specificity, tissue morphology and
overall staining quality. For a detailed break-up, refer to
the supplement (see Additional file 1).
Fluorescence in situ hybridization
We used fluorescence in-situ hybridization (FISH) assay
to detect the ERG rearrangement at the chromosomal
level on each specimen [25,26]. Hence, we performed a
split-signal-approach, with two probes spanning the
ERG locus as described earlier. For FISH assays, 5 μm
sections of all samples were mounted on superfrost
slides. All cases were independently assessed by two
experienced evaluators (M.B., and S.P.) At least 100
nuclei per case were evaluated. Criteria for an efficient
FISH staining were clear distinguishable cell morphology
with strong distinct ERG signals within the nuclei, and
minimal background signals. See full protocol in the
supplement (see Additional file 1).
DNA extraction
DNA extraction was performed using the routine Phe-
nol:Choroloform: Isoamylalcohol (PCI) method. For sub-
sequent DNA quality assessment using PCR, we chose 6
FFPE specimens, along with their corresponding HOPE
and fresh-frozen samples, each having a sufficient
amount of DNA and a high integrity value for all the
three preservation methods. See full protocol in the sup-
plement (see Additional file 1).
PCR
For the assessment of amplifiability and integrity of
DNA samples a control gene PCR was performed using
five control genes exon and five primer sets for obtain-
ing PCR products ranging from 100 to 600 bp. This was
followed by a gel electrophoresis to analyse the bands of
the corresponding PCR products. As reported by Van
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control genes, ranging from 100 to 600 bp, is a good
representation of DNA integrity and amplifiability. For a
detailed break-up, refer to supplement (see Additional
file 1).
RNA extraction
Tissue sections were prepared, using a RNAse-free
microtome and 1.5 ml RNAse-free tubes. For FFPE and
HOPE fixed tissues, xylene and ethanol deparaffinization
step was performed according to the manufacturer’s
recommendations. For each block, the topmost five sec-
tions were discarded and only the adjoining deeper sec-
tions (ten per sample) were then cut and deparaffinised.
RNA was isolated using the column-based purification
protocol with QIAGEN RNeasy FFPE kit (QIAGEN
GmbH, Hilden, Germany).
RNA integrity and quantity was estimated using the
NanoDrop 1000 C Spectrophotometer (NanoDrop
Technologies, Wilmington, DE, USA). Residual DNA
was destroyed by treatment with DNase (Qiagen). For
quantitative RT-PCR, we chose the six most promising
FFPE and corresponding HOPE and fresh-frozen speci-
mens, having a sufficient amount of RNA and a high
integrity value.
Quantitative RT-PCR
Quantitative RT-PCR analysis was performed with the
Roche Light Cycler 480 (Roche, Switzerland). cDNA was
synthesized by reverse transcriptase (Revert Aid H Mini
First Strand cDNA Synthesis Kit, Fermentas Life
Sciences) using 100 ng of total RNA and an oligo dT15
primer provided in the kit. We quantified three house-
keeping genes (TBP, GAPDH, b-actin) with varying
amplicon lengths to check for RNA integrity from FFPE,
HOPE and fresh frozen samples. See full protocol in
supplement (see Additional file 1).
Protein extraction and western blot
Protein extraction was performed on FFPE, HOPE and
fresh-frozen samples [27,28] and protein concentrations
were determined using the Bradford protein assay
(BioRad Protein Assay (# 500-0006)). Equal amounts of
protein lysates (18 μg) were separated by one-dimen-
sional SDS-polyacrylamide (10%) gel electrophoresis and
blotted onto nitrocellulose membranes (Schleicher and
Schuell, Dassel, Germany). Protein detection was per-
formed using anti-b-Actin (Sigma A1978 AC15,
1:10.000 in 5% milkpowder/TBST), anti-PSA (Novocas-
tra #NCL-PSA-431, 1:1000 in 5% milkpowder/TBST)
and anti-GOLPH2 antibodies (Abnova #H00051280-
M06, 1:1000 in 5% milkpowder/TBST). See a detailed
protocol in the supplement. Western blot quantification
was performed using Scion Image software (Scion Corp.,
Frederick, MD, USA). For protein yield calculation the
area of the sections was measured using AxioVision Rel.
4.8 (Carl Zeiss Imaging Solutions GmbH, Göttingen,
Germany), and the yield (X) was calculated as follows:
Totalprotein amount/(area ∗ section thickness ∗ numberofsections) = Xµg/mm3
Statistical analysis
For statistical analysis SPSS Statistics 19 was used (SPSS
Inc., Chicago, IL). In order to assess the differences in
performance in the three fixation subsets, we performed
the Student’s t-test and Friedman test. A p-value lower
than 0.05 was considered to be statistically significant.
Results
Prior to DNA and RNA extraction and evaluation, spe-
cimens were examined on a histological basis. Conven-
tionally used pathological techniques, such as HE
staining, immunohistochemistry (IHC) and FISH were
carried out for all samples (i.e. FFPE-fixed specimens,
HOPE-fixed specimens, fresh-frozen specimens). HOPE
specimens constantly displayed a ‘FFPE-like’ histomor-
phology with specific signals for each of the above men-
tioned techniques. As expected, fresh frozen specimens
showed typical freeze-related artefacts regarding histolo-
gic quality, such as freeze artefacts, partially distorted
morphology, and interfering background.
IHC staining of HOPE samples was time-efficient
compared to the FFPE specimens, as no epitope retrieval
was necessary. However, unlike the HOPE-manufac-
turer’s recommendation for the FISH assay, a brief pro-
teinase pretreatment was needed for HOPE specimens
to enhance signal quality. The results are displayed and
summarized in Figure 1
To analyze the feasibility to amplify the extracted
DNA, we performed a PCR with a set of five primers of
different sizes and analyzed all the amplicons on a 2%
agarose gel, stained with ethidium bromide. Depending
on the fixation method, we observed differences in the
DNA quality. A total of the mentioned five bands were
expected - 100 bp, 200 bp, 300 bp, 400 bp, and 600 bp.
All samples effectively amplified bands of up to 400 bp.
HOPE and fresh-frozen specimens displayed all five dis-
tinct bands, while the FFPE samples showed the absence
of the 600 bp band, as depicted in Figure 2a-c.
To compare the potential of the different fixation
techniques for the detection and quantification of RNA,
real time RT-PCR was performed. RNA was extracted
from six patient samples, i.e. six HOPE specimens and
their corresponding FFPE and fresh-frozen specimens.
The reverse transcribed cDNA, obtained from the
extracted RNA, was then used to detect the Ct value. A
quantitative RT-PCR of three housekeeping genes (TBP,
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performed for all specimens.
As expected, on an average, the cycle threshold (Ct)
derived from the fresh frozen specimens, naturally lack-
ing any fixative interference, showed the lowest Ct values,
followed by HOPE and FFPE specimens. (Figure 3) The
average Ct threshold HOPE values for TBP, GAPDH and
b-actin were 29.2, 27.8, and 27.6 respectively. The aver-
age Ct threshold FFPE values for TBP, GAPDH and b-
actin were 33.2, 34.5, and 35.5, respectively. The average
Ct threshold of fresh-frozen specimens values for TBP,
GAPDH and b-actin were 27.1, 26.4, 25.8 respectively. Of
note, these differences in the average Ct were statistically
significant (p < 0.05, t-test). See Table 1 for a detailed
break-up of the different Ct values.
To compare protein quality and quantity, western
blot analysis and protein yield calculations were per-
formed. In the western blot analysis we detected strong
signals at 34 kDa, 45-50 kDa and 42 kDa using antibo-
dies against PSA, GOLPH2 and beta-Actin, respec-
tively, independent of the preservation method. We
Figure 1 Morphological quality comparison between FFPE,
HOPE, and fresh-frozen specimens. a. Representative HE stained
sections of FFPE, HOPE, and fresh frozen material. Tissue sections of
HOPE fixed prostate cancer specimens show a ‘FFPE -like’
morphology. As expected, frozen tissue displayed typical indistinct
cytomorphology. b. Representative p63 antibody
immunohistochemistry staining of FFPE, HOPE, and fresh frozen
material. FFPE and frozen sample display benign glands and
infiltrating prostate cancer glands. The HOPE sample depicts
infiltrating tumor glands and an intraductal spread of the prostate
cancer. In the FFPE and frozen samples, the p63 antibody highlights
the basal cells of the normal prostatic glands. In the HOPE sample,
the p63 antibody highlights the basal cells of the gland with
intraductal tumor spread. In all samples, the infiltrative prostate
cancer glands are negative for p63 staining. The efficient binding
specificity and signal strength of all samples is comparable, while
the histomorphologic quality is inferior in the frozen sample. c.
Representative Fluorescence in-situ hybridisation of ERG
rearrangement on FFPE, fresh frozen and HOPE tissue sections. High
power magnification. FISH for ERG on formalin-fixed, paraffin-
embedded prostate cancer tissue. As expected for fresh-frozen
samples, signals are specific, but the tissue section exhibits a typical
freeze-related clumping of cells with a lack of distinct morphology.
On the other hand, FISH for ERG on HOPE fixed prostate cancer
tissue show a ‘FFPE-like’ signal specificity and morphology.
Figure 2 DNA integrity of FFPE, HOPE, and fresh-frozen tissues.
Control gene PCR for the assessment of amplification and integrity
of DNA samples obtained from FFPE, HOPE, and fresh frozen tissues.
Gel electrophoresis of five control gene exon PCR products ranging
from 100 to 600 bp. a. FFPE derived DNA samples. Clear bands
were observed for 4 control genes. The 600 bp band was visible
only in lane 6, suggesting a certain amount of DNA degradation. b.
HOPE derived DNA samples. Clear bands were observed for all 5
control genes. Results were comparable to the DNA extracted from
fresh frozen samples, suggesting good DNA integrity. c. Fresh frozen
derived DNA samples. Clear bands were observed for all 5 control
genes suggesting good DNA integrity, as expected.
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which were at least as intense as those of cryopre-
served and FFPE samples. Interestingly, in the tumor
sample of case #3 high PSA and low GOLPH2 expres-
sion could be detected, independent of the preserva-
tion method (Figure 4). The quantification of the
western blots and normalization against beta-Actin
revealed for most of the samples no significant differ-
ences between the signal intensities from cryopre-
served, HOPE-fixed or formalin-fixed samples. FFPE
showed for some cases even the strongest signal which
might be dependent on the epitope detected by the
specific antibody or due to a very weak beta-Actin
staining for those FFPE samples (Figure 5a and 5b).
The resulting protein yields were similar or even
higher for HOPE and FFPE tissues compared to cryo-
preserved samples. However, by taking into account all
cryopreserved, FFPE, and HOPE samples no statisti-
cally significant differences could be observed (p =0 . 3 ,
Friedman test) (Figure 5c).
Figure 3 RNA integrity of FFPE, HOPE, and fresh-frozen tissues.
Representative real-time RT-PCR targeting TATA-binding-protein
(TBP, 73 bp) in FFPE, HOPE, and fresh-frozen tissues. The threshold
value of HOPE fixed specimens was comparable to that of the fresh-
frozen specimen.
Table 1 RNA Quality Assessment.
TBP
FFPE HOPE Native
29,9 27,15 25,5
31,89 29,18 27,2
34,8 29,8 28,1
33,6 29,7 27,5
33,1 29,9 26,3
35,86 29,6 28,2
GAPDH
FFPE HOPE Native
29,4 25,5 25,1
35,8 29,7 27,4
37,7 27,9 25,6
31,7 28 27,3
36,2 27,9 25,7
35,9 27,8 27,1
Beta actin
FFPE HOPE Native
36,9 28,2 26,7
38,7 25,6 24,1
31,8 31,1 25,8
34,2 26 25,5
33,2 29,3 28,1
38,12 25,7 24,8
Cycle threshold values for TBP, GAPDH and ß-actin from the corresponding
FFPE, HOPE, and fresh-frozen samples.
Figure 4 Western blot analysis of FFPE, HOPE, and fresh-frozen
samples using PSA (34 kDa), GOLPH2 (45-50 kDa), and beta-
actin (42 kDa) antibodies. Eighteen μg of protein was separated
by SDS-PAGE and western blot analysis was performed using
indicated antibodies. Strong bands could be detected at 34 kDa
with the anti-PSA antibody (a) and at 45-50 kDa with the anti-
GOLPH2 antibody (b). The housekeeping gene beta-actin also
showed clear bands at 42 kDa. Signal intensities of HOPE-fixed
tissue specimens were at least as intense as those of cryopreserved
and FFPE samples.
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The availability of well-annotated human prostatic tissue
samples through biobanks is key for translational
research [1-4]. Due to the nature of prostate carcinomas
developing multiple and independent tumor foci, which
are tedious to identify macroscopically, it is recom-
mended to freeze each second prostate tissue slice.
Thus, comprehensive prostate cancer biobanking
requires enormous amounts of resources [2,5-7]. How-
ever, this is in conflict with the existing guidelines
requiring all prostatic tissue to be used for diagnostic
purposes. By this means, the amount of fresh-frozen tis-
sue available for research is limited. FFPE tissues, as
used in diagnostics, are easy to handle and economic to
store, but their applicability for subsequent research is
restricted [7-12]. On the other hand, the sparsely avail-
able fresh-frozen tissue is most applicable to a broad
spectrum of molecular analyses, but its storage and
handling is complex and cost-intensive. The recently
introduced, formalin-free HOPE-fixation method is a
promising alternative, having the potential to unite the
benefits of FFPE and fresh-frozen specimens. This fixa-
t i o nm e t h o dm a yb ea b l et ob r i d g et h ea b o v e - d e s c r i b e d
gap of available, superior quality tissue, and thus resolve
the conflict faced by both diagnostic and research.
Recently, HOPE-fixed material has been used in few stu-
dies and the feasibility of this fixation technique has
been assessed on different human tissues [13-24].
This is the first comparative study simultaneously ana-
lysing the molecular and morphological integrity of
FFPE, HOPE and fresh-frozen prostate cancer specimens
from the same samples. Our results for the HOPE fixed
specimens suggested that problematic factors such as
distinct nucleic acid degradation and methylene cross
linking are absent. In terms of morphology, the HOPE
fixed specimens displayed a superior and formalin-like
quality. In addition, for IHC assessment of HOPE sam-
ples, no antigen-retrieval was required. For in-situ analy-
sis, even though the manufacturer recommended no
enzymatic digestion, our study showed that the FISH
signals in HOPE samples benefited with enzymatic pre-
treatment. Furthermore, DNA, RNA and protein integ-
rity of the HOPE samples were comparable to the fresh-
frozen samples, yielding far better results than the FFPE
specimens for most of the approaches investigated in
this study. PCR results indicate that DNA extracted
from HOPE, FFPE and fresh-frozen samples is suitable
for downstream molecular applications. As expected,
DNA isolated from FFPE specimens was highly frag-
mented as compared to the HOPE and fresh-frozen spe-
cimens, but could be used for successful amplification of
Figure 5 Western blot quantification and protein yield
calculations. Western blot quantification was performed using
Scion Image software. Depicted are the signal intensities of anti-PSA
(a) and anti-GOLPH2 (b) antibodies, normalized to beta-Actin. The
quantification of the western blots revealed for most of the samples
no differences between the signal intensities from cryopreserved,
HOPE-fixed or formalin-fixed samples. FFPE showed for some cases
even the strongest signal which might be dependent on the
epitope detected by the specific antibody or due to a very weak
beta-Actin staining for those FFPE samples. For protein yield
calculations (c) the area of the sections was measured using
AxioVision Rel. 4.8 and the yield was calculated for each sample.
The resulting protein yields were similar or even higher for HOPE
and FFPE tissues compared to cryopreserved samples.
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Thus, on the molecular basis, HOPE fixation has proven
to be promising, providing similar results as fresh-frozen
specimens, without significant reduction in quality or
the amount of extractable nucleic acids. On the same
hand, HOPE fixed specimens equally displayed ‘FFPE-
like’ morphology. However, HOPE fixation has certain
limitations. Manufacturer recommends storage of HOPE
fixed specimens at 4°C. Extensive studies have not been
performed on long-term storage issues. Moreover HOPE
protocols for fixation are relatively long, and tissue
blocks are tougher to handle due to a lower melting
point of the paraffin material. Lastly, and most impor-
tantly, the HOPE technique does not completely fix the
tissue, resulting in a potential hazard of viral, prion,
micro-organism infection.
Nevertheless, with regard to today’sd i a g n o s t i ca n d
research pathology, HOPE fixation has a promising
potential to add to the current fixation approaches. This
method could easily be implemented in the research
a n dd i a g n o s t i cs u r r o u n d i n g s ,a st h es a m ei n s t r u m e n t s
are needed as required for FFPE processing and section-
ing. On the other hand, regarding costs, FFPE is by far
the cheapest method to preserve tissue specimens. How-
ever, HOPE fixation is cheaper than cryopreservation,
especially when it comes to numerous samples. This is
due to the fact that HOPE samples can economically be
stored in refrigerators, are easier to handle, and do not
have space constraints due to the cassette frames. None-
theless, a remaining limiting factor might be the amount
of time needed for the manual HOPE fixation protocol
as compared to the widely used and highly standardized
automatic FFPE protocol. But to our knowledge, an
automated HOPE fixation device is currently available in
the market.
Lastly, the fixation protocols followed in our bio-repo-
sitory may not necessarily be identical to fixation
approaches applied elsewhere. Consequently, follow up
studies using a larger cohort are needed to address
these aspects in detail, such as the impact of different
conditions (e.g. time, concentration, temperature, etc.),
on quality and integrity of the specimens.
Conclusions
In conclusion, this is the first study comparing in paral-
l e lH O P Ef i x e db i o - s p e c i m e n sw i t hF F P Ea n df r e s h - f r o -
zen samples for their suitability for diagnostic and
research utilization. We were able to illustrate that
HOPE specimens largely combine the advantages of
FFPE and fresh-frozen material. Our studies show that
the HOPE fixation could be a promising alternative for
initial prostate tissue storage, enabling comprehensive
research upon routine diagnosis. Results of this study
have the potential to expand on contemporary prostate
tissue biobanking approaches and can furthermore be a
model for other organs and tumors.
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